Contract 36C25725N0190
Novartis Pharmaceuticals Corporation · Department Of Veterans Affairs · March 24, 2026
Novartis Pharmaceuticals Corporation was awarded a federal contract by Department Of Veterans Affairs on March 24, 2026 for $2.64 million (current value) of work in pharmaceutical preparation manufacturing. Performance is in East Hanover, NJ. This is a task or delivery order issued under parent IDIQ 36F79720D0180. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $2.64 million.
Contract details
- PIID
- 36C25725N0190
- Parent IDIQ
- 36F79720D0180
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- East Hanover, NJ
- First action
- March 24, 2026
Description
LUTATHERA & PLUVICTO - DE-OBLIGATE EXCESS FUNDS
Modification timeline
-
March 24, 2026Mod P00001 · Funding Only Action$2.64M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25725N0190?
Contract 36C25725N0190 is a federal contract awarded to Novartis Pharmaceuticals Corporation by Department Of Veterans Affairs on March 24, 2026 for $2.64 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 36C25725N0190?
Novartis Pharmaceuticals Corporation won contract 36C25725N0190 from Department Of Veterans Affairs.
How much is contract 36C25725N0190 worth?
Contract 36C25725N0190 has obligated $0 to date but carries a potential ceiling of $2.64 million if fully funded and all options are exercised.